Leveraging their experience with clinical development and laboratory services through all development phases, PPD’s experts discuss four common patterns that have emerged from day-to-day involvement with COVID trials that can help ensure the success of your next program.
Specialized, innovative and well-informed protocols
A variety of COVID-19 testing capabilities, technologies and applications
Consideration for rapid global regulatory changes
Partnership with a contract research organization (CRO) to shorten development timelines
who should attend?
Senior Level Professionals
Managers and Department Heads Involved In Clinical Research
Vaccine/Pharmaceutical Research and Development Personnel
CAROL OLSON, MD, PHD
Senior Vice President, Global Product Development, Therapeutic Area Head, Infectious & Respiratory Diseases and Vaccines, PPD